Award
National Institute of Arthritis and Musculoskeletal and Skin Diseases 1R01AR086588-01A1
Cartilage targeting exosomes for OA gene therapy and pain treatment
Recipient
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Award Amount
$652,195.00
Ceiling
$652,195.00
Awarded
June 19, 2026
Identifier
1R01AR086588-01A1
NIAMS awarded $652,195 for a project developing cartilage-targeting exosomes for osteoarthritis gene therapy and pain treatment, running from June 2026 to May 2031.
Description
The project focuses on engineering cartilage-targeting exosomes for gene therapy and pain treatment in osteoarthritis. The project involves developing non-viral carriers, engineering charge-reversed exosomes, and evaluating their efficacy in vitro and in vivo.